Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
24 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
PRE 14A
Preliminary proxy
11 Apr 24
S-8
Registration of securities for employees
1 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Departure of Directors or Certain Officers
15 Feb 24
8-K
Departure of Directors or Certain Officers
29 Jan 24
8-K/A
Independent Auditors’ Report
5 Jan 24
8-K
Other Events
3 Jan 24
8-K
Termination of a Material Definitive Agreement
22 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Departure of Directors or Certain Officers
26 Oct 23
8-K
Entry into a Material Definitive Agreement
23 Oct 23
8-K
Entry into a Material Definitive Agreement
6 Sep 23
8-K
Departure of Directors or Certain Officers
10 Aug 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Entry into a Material Definitive Agreement
24 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
14 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 23
DEF 14A
Definitive proxy
14 Apr 23
8-A12B
Registration of securities on exchange
5 Apr 23
8-K
Entry into a Material Definitive Agreement
5 Apr 23
PRE 14A
Preliminary proxy
4 Apr 23
8-K
Departure of Directors or Certain Officers
28 Mar 23
S-8
Registration of securities for employees
15 Mar 23
10-K
2022 FY
Annual report
15 Mar 23
8-K
Departure of Directors or Certain Officers
3 Mar 23
8-K
Results of Operations and Financial Condition
30 Jan 23
8-K
Entry into a Material Definitive Agreement
27 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 Dec 22
10-Q
2022 Q3
Quarterly report
9 Nov 22
8-K
Departure of Directors or Certain Officers
30 Sep 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
8-K
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
1 Aug 22
8-K
Departure of Directors or Certain Officers
22 Jul 22
8-K
Entry into a Material Definitive Agreement
10 Jun 22
Latest ownership filings
4
Rajiv Patni
15 Feb 24
3
Rajiv Patni
15 Feb 24
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 24
SC 13G
Sofinnova Partners SAS
12 Feb 24
SC 13G/A
BML Investment Partners, L.P.
7 Feb 24
4
Charles S. Ryan
2 Feb 24
4
Brendan Hannah
2 Feb 24
4
Dirk Thye
2 Feb 24
4
Dirk Thye
17 Jan 24
SC 13G
Genextra S.p.A.
15 Dec 23
4
David Lamond
14 Dec 23
4
David Lamond
7 Dec 23
4
David Lamond
1 Dec 23
4
Brendan Hannah
26 Oct 23
4
Luca Benatti
24 Oct 23
3
Luca Benatti
24 Oct 23
4
Guenter Janhofer
24 Oct 23
3
Guenter Janhofer
24 Oct 23
4
Charles S. Ryan
6 Sep 23
3
Charles S. Ryan
6 Sep 23
4
David Lamond
31 Aug 23
4
David Lamond
17 Aug 23
4
Dirk Thye
11 Aug 23
4
Dirk Thye
9 Aug 23
4
Brendan Hannah
9 Aug 23
4
Margaret McLoughlin
9 Aug 23
SC 13G
BML Investment Partners, L.P.
17 Jul 23
4
Christopher J. Senner
26 May 23
4
UNA S RYAN
26 May 23
4
Margaret McLoughlin
26 May 23
4
David Lamond
26 May 23
4
June Bray
26 May 23
SC 13G
TANG CAPITAL PARTNERS LP
31 Mar 23
4
Ted Monohon
6 Mar 23
SC 13G/A
EPQ LLC, CTYM PS
13 Feb 23
4
Dirk Thye
2 Feb 23
4
Karen L. Smith
2 Feb 23
4
Ted Monohon
2 Feb 23
4
Brendan Hannah
2 Feb 23
4
Ted Monohon
7 Dec 22